VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,247,764 | +528.1% | 880,231 | +1544.2% | 0.01% | +800.0% |
| Q2 2023 | $1,313,214 | -16.1% | 53,535 | -20.5% | 0.00% | -50.0% |
| Q1 2023 | $1,566,071 | +37.5% | 67,300 | +49.6% | 0.00% | +100.0% |
| Q4 2022 | $1,138,823 | +298.2% | 44,995 | +203.7% | 0.00% | – |
| Q3 2022 | $286,000 | +30.6% | 14,818 | +72.5% | 0.00% | – |
| Q2 2022 | $219,000 | -83.7% | 8,588 | -83.6% | 0.00% | -100.0% |
| Q1 2022 | $1,343,000 | -77.8% | 52,230 | -63.9% | 0.00% | -80.0% |
| Q4 2021 | $6,063,000 | -16.6% | 144,802 | -13.4% | 0.01% | -28.6% |
| Q3 2021 | $7,274,000 | -29.8% | 167,126 | -23.8% | 0.01% | -22.2% |
| Q2 2021 | $10,365,000 | +73.9% | 219,228 | +88.5% | 0.01% | +50.0% |
| Q1 2021 | $5,962,000 | +931.5% | 116,292 | +439.1% | 0.01% | +500.0% |
| Q4 2020 | $578,000 | – | 21,571 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |